The PKG™ system provides continuous, objective, ambulatory assessment of movement disorder symptoms, such as tremor, dyskinesia and bradykinesia during activities of daily living and in the patient's home environment.
Consisting of an interactive watch that collects movement data, proprietary algorithms and a detailed report, the PKG™ system also correlates the frequency and severity of symptoms with respect to consumption of prescribed medication.
-
11 April 2018Read More
The Australian Federal Government’s Biomedical Translation Fund has invested $7.7.million in the commercialization of GKC’s Parkinson’s KinetiGraph™ (PKG™) as the company makes inroads to obtaining re…
-
23 July 2018Read More
Global Kinetics Pty Ltd. (GKC) today announced that the American Medical Association (AMA) has issued a set of new Category III Current Procedural Terminology® (CPT®) codes that describe the services …
-
21 August 2018Read More
In the most recent of a series of significant clinical milestones, Global Kinetics’ innovative wearable technology, the Personal KinetiGraph™ (PKG™), has been recommended by two separate expert panels…